失调
抗生素
殖民抵抗
肠道菌群
抗生素耐药性
利福昔明
微生物群
生物
艰难梭菌
合生元
双歧杆菌
微生物学
免疫学
医学
生物信息学
乳酸菌
益生菌
细菌
遗传学
作者
Gaia Cusumano,Giancarlo Angeles Flores,Roberto Venanzoni,Paola Angelini
出处
期刊:Antibiotics
[Multidisciplinary Digital Publishing Institute]
日期:2025-04-03
卷期号:14 (4): 371-371
被引量:134
标识
DOI:10.3390/antibiotics14040371
摘要
The human gut microbiota—an intricate and dynamic ecosystem—plays a pivotal role in metabolic regulation, immune modulation, and the maintenance of intestinal barrier integrity. Although antibiotic therapy is indispensable for managing bacterial infections, it profoundly disrupts gut microbial communities. Such dysbiosis is typified by diminished diversity and shifts in community structure, especially among beneficial bacterial genera (e.g., Bifidobacterium and Eubacterium), and fosters antibiotic-resistant strains and the horizontal transfer of resistance genes. These alterations compromise colonization resistance, increase intestinal permeability, and amplify susceptibility to opportunistic pathogens like Clostridioides difficile. Beyond gastrointestinal disorders, emerging evidence associates dysbiosis with systemic conditions, including chronic inflammation, metabolic syndrome, and neurodegenerative diseases, underscoring the relevance of the microbiota–gut–brain axis. The recovery of pre-existing gut communities post-antibiotic therapy is highly variable, influenced by drug spectrum, dosage, and treatment duration. Innovative interventions—such as fecal microbiota transplantation (FMT), probiotics, synbiotics, and precision microbiome therapeutics—have shown promise in counteracting dysbiosis and mitigating its adverse effects. These therapies align closely with antibiotic stewardship programs aimed at minimizing unnecessary antibiotic use to preserve microbial diversity and curtail the spread of multidrug-resistant organisms. This review emphasizes the pressing need for microbiota-centered strategies to optimize antibiotic administration, promote long-term health resilience, and alleviate the disease burden associated with antibiotic-induced dysbiosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI